The relevance of blood clotting tests in chronic aggressive hepatitis.
D000704:Analysis of Variance; D000991:Antithrombins / Q000378:metabolism; D001706:Biopsy; D001780:Blood Coagulation Tests; D001797:Blood Protein Electrophoresis; D002908:Chronic Disease; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation; D005165:Factor V / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use; D006505:Hepatitis / Q000097:blood* / Q000473:pathology; D006801:Humans; D007122:Immunoelectrophoresis; D007202:Indicators and Reagents; D008111:Liver Function Tests; D008259:Macroglobulins / Q000378:metabolism; D008722:Methods; D011517:Prothrombin Time; D012709:Serum Albumin
D000991:Antithrombins; D003509:Cyclohexanecarboxylic Acids; D007202:Indicators and Reagents; D008259:Macroglobulins; D012709:Serum Albumin; D005165:Factor V; D005170:Factor X; D005340:Fibrinogen; D006493:Heparin